Walmar Clinical ApS: Financial statements 2025
CVR: 43237381
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Walmar Clinical ApS (CVR 43237381) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,847,721 and a net result of DKK 527,965 compared with DKK 623,346 the year before. That is a decrease of 5.1% compared with the year before. Equity in the 2025 report amounted to DKK 932,122. The solvency ratio was 34.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,847,721
- Profit/Loss
- DKK 527,965
- Equity
- DKK 932,122
- Total Assets
- DKK 2,684,273
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.8 mio. | 528 t. | 932 t. | 1 |
| 2024 | - | 1.9 mio. | 623 t. | 666 t. | 1 |
| 2023 | - | 1.9 mio. | 725 t. | 775 t. | 1 |
Official annual report
How creditworthy is Walmar Clinical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Walmar Clinical ApS has published its annual report for 2024. Gross profit came to DKK 1,946,435, and the net result was DKK 623,346.
About Walmar Clinical ApS
Walmar Clinical ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Walmar. The company is owned by 26c Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,847,721 and a net result of DKK 527,965 compared with DKK 623,346 the year before. Equity in the 2025 report amounted to DKK 932,122.